Goiter screening

Jump to navigation Jump to search

Goiter Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Goiter from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Goiter screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Goiter screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Goiter screening

CDC on Goiter screening

Goiter screening in the news

Blogs on Goiter screening

Directions to Hospitals Treating Cushing’s disease

Risk calculators and risk factors for Goiter screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aravind Reddy Kothagadi M.B.B.S[2]

Overview

Screening for goiter initially involves physical examination followed by blood tests for free T4 and TSH and finally thyroid scan, ultrasound and biopsy to rule out malignancy.

Screening

Screening for goiter includes the following approaches and progresses to the next approach based on the result of earlier screening procedure: [1][2][3][4][5][6]

Physical exam:

Blood Tests:

Further evaluation to rule out malignancy:

References

  1. Ladenson PW (1996). "Optimal laboratory testing for diagnosis and monitoring of thyroid nodules, goiter, and thyroid cancer". Clin. Chem. 42 (1): 183–7. PMID 8565224.
  2. Dietlein M, Moka D, Schmidt M, Theissen P, Schicha H (2003). "[Prevention, screening and therapy of thyroid diseases and their cost-effectiveness]". Nuklearmedizin (in German). 42 (5): 181–9. PMID 14571314.
  3. COLE WH, MAJARAKIS JD, SLAUGHTER DP (1949). "Incidence of carcinoma of the thyroid in nodular goiter". J Clin Endocrinol Metab. 9 (10): 1007–11. doi:10.1210/jcem-9-10-1007. PMID 18142433.
  4. "Reorganized text". JAMA Otolaryngol Head Neck Surg. 141 (5): 428. 2015. doi:10.1001/jamaoto.2015.0540. PMID 25996397.
  5. Gursoy A, Anil C, Unal AD, Demirer AN, Tutuncu NB, Erdogan MF (2008). "Clinical and epidemiological characteristics of thyroid hemiagenesis: ultrasound screening in patients with thyroid disease and normal population". Endocrine. 33 (3): 338–41. doi:10.1007/s12020-008-9095-5. PMID 19016002.
  6. Brander A, Viikinkoski P, Nickels J, Kivisaari L (1989). "Thyroid gland: US screening in middle-aged women with no previous thyroid disease". Radiology. 173 (2): 507–10. doi:10.1148/radiology.173.2.2678263. PMID 2678263.

Template:WH Template:WS